Gene and protein expression of glucose transporter 1 and glucose transporter 3 in human laryngeal cancer-the relationship with regulatory hypoxia-inducible factor-1α expression, tumor invasiveness, and patient prognosis.
about
Clinical relevance of the tumor microenvironment and immune escape of oral squamous cell carcinomaRole of multifaceted regulators in cancer glucose metabolism and their clinical significanceInterplay Between Metabolism and Oncogenic Process: Role of microRNAsTargeting Tumor Metabolism for Cancer Treatment: Is Pyruvate Dehydrogenase Kinases (PDKs) a Viable Anticancer Target?Integrated Analysis of Long Noncoding RNA and mRNA Expression Profile in Advanced Laryngeal Squamous Cell Carcinoma.Knockdown of PKM2 Suppresses Tumor Growth and Invasion in Lung Adenocarcinoma.Stilbenoids remodel the DNA methylation patterns in breast cancer cells and inhibit oncogenic NOTCH signaling through epigenetic regulation of MAML2 transcriptional activity.Integrative radiogenomic analysis for genomic signatures in glioblastomas presenting leptomeningeal dissemination.Ghrelin promotes oral tumor cell proliferation by modifying GLUT1 expression.Metabolic Cooperation and Competition in the Tumor Microenvironment: Implications for Therapy.The prognostic value of GLUT1 in cancers: a systematic review and meta-analysis.Role of long non-coding RNAs in glucose metabolism in cancer.Hypoxia promotes the invasion and metastasis of laryngeal cancer cells via EMT.The c.*229C > T gene polymorphism in 3'UTR region of the topoisomerase IIβ binding protein 1 gene and LOH in BRCA1/2 regions and their effect on the risk and progression of human laryngeal carcinoma.Detection of human breast cancer cells using a 2-deoxy-D-glucose-functionalized superparamagnetic iron oxide nanoparticles.Individualized outcome prognostication for patients with laryngeal cancer.MiR-34c induces apoptosis and inhibits the viability of M4e cells by targeting BCL2.Gene/protein expression of CAPN1/2-CAST system members is associated with ERK1/2 kinases activity as well as progression and clinical outcome in human laryngeal cancer.Fibroblast growth factor receptor 1 and 3 expression is associated with regulatory PI3K/AKT kinase activity, as well as invasion and prognosis, in human laryngeal cancer.
P2860
Q26752515-6182C9B1-CB47-40B0-B177-54FEEB3E3EB0Q26765039-E3946F7B-9374-4BE0-8BA0-F8D906EA88EFQ26770381-61539DE0-478E-420C-A8AD-55041EBCBD54Q26774957-A5ED9013-531A-4E1F-9CD9-0CC957155C3BQ36235850-DB8970F3-23A5-4246-A2D0-A0D3150E5354Q36247437-FE447D69-B41E-4B50-8101-3C6A1579893AQ37074064-B2F24D36-5779-4CED-B93A-3F209F30BFE9Q37328080-E1B66D58-9B9E-44F6-B491-1408D952BCE4Q38832450-9EA97BE9-3A2F-480A-9DFD-968E6334B5E1Q39265746-E897B798-4A6B-49E2-8B02-11759B55BE2BQ39302663-0B5E9B70-8BBD-4BC0-B313-874F4D1D8E91Q39454788-448AFC4F-349B-4D40-9A65-2369FD919AE8Q40988474-D9E1F541-73A0-4B86-A015-44EE5258B0E2Q41184434-94841818-153E-4C72-86B3-55EFF5632882Q47884463-725ACEEC-894A-4A0C-BAB7-7E4905E6691EQ48350346-C406E8E3-13EE-4341-BAFD-F7E7E74CE08BQ50053177-E9797C35-0B51-4C7C-8E3C-907166FD50F5Q51617592-B54C2D14-C93A-42D5-ABC1-4777B95EADEBQ54985778-B4BF5FAE-4C75-47DB-A1CC-EC028511933B
P2860
Gene and protein expression of glucose transporter 1 and glucose transporter 3 in human laryngeal cancer-the relationship with regulatory hypoxia-inducible factor-1α expression, tumor invasiveness, and patient prognosis.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Gene and protein expression of ...... veness, and patient prognosis.
@ast
Gene and protein expression of ...... veness, and patient prognosis.
@en
type
label
Gene and protein expression of ...... veness, and patient prognosis.
@ast
Gene and protein expression of ...... veness, and patient prognosis.
@en
prefLabel
Gene and protein expression of ...... veness, and patient prognosis.
@ast
Gene and protein expression of ...... veness, and patient prognosis.
@en
P2093
P2860
P50
P1433
P1476
Gene and protein expression of ...... iveness, and patient prognosis
@en
P2093
Iwona Lewy-Trenda
Katarzyna Starska
Paweł Jóźwiak
P2860
P2888
P304
P356
10.1007/S13277-014-2838-4
P577
2014-11-21T00:00:00Z